Similarly, gold nanoparticles bioconjugated with cetuximab to target EGFR were investigated in cell lines overexpressing EGFR and showed consistent and effective targeting both in vitro and in vivo in NMRI nude mice bearing A431 epidermoid carcinoma tumors [127]. Here, EGFR is linked to squamous cell carcinoma.